Fall 2001 Seminar Series
STAT 598E: Statistical Applications in Pharmaceutical Research and Development
Mondays, 4:30 PM, LAEB B222
This special seminar series, which focuses on statistical methods and issues in the pharmaceutical industry, is a joint initiative between the Statistical and Mathematical Sciences Department of Eli Lilly & Company and the Department of Statistics of Purdue University at West Lafayette, Indiana. The lectures will be given by a team of Eli Lilly statisticians.
The goal of the series is to introduce students and faculty at the university to the broad spectrum of issues surrounding the drug development process in a pharmaceutical industry. The gamut of activities covering discovery, development, manufacturing, and marketing of pharmaceutical agents will be discussed. The statistical content of the seminars will be directed to students knowledgeable about statistics as well as the general interested audience.
The series is also offered as a one credit course, labeled STAT 598E, for Fall 2001 at Purdue. The instructor and coordinator is Professor M.E. Bock and the prerequisite is an introductory statistics course. The course meets Mondays, 4:30 PM, in LAEB B222. For further information, please contact Professor Bock by email at mbock@stat.purdue.edu or by phone at 765-494-3141.
The first seminar is Monday, August 20, 2001, 4:30 PM, LAEB B222.
Schedule
Monday, August 20, 2001, 4:30 PM in LAEB B222
Dr. J. P. Wery, Eli Lilly & Company
Overview of Drug Discovery and Development. Role of Statistics and Information Sciences
Monday, August 27, 2001, 4:30 PM in LAEB B222
Dr. Ann Marie Crawford, Eli Lilly & Company
Drug Hunting: Impact and Influence of Statistical Science on Regulated Drug Development
Monday, September 10, 2001, 4:30 PM in LAEB B222
Dr. Richard Higgs, Eli Lilly & Company
Statistical Perspectives for Molecular Diversity
Monday, September 17, 2001, 4:30 PM in LAEB B222
Dr. Wendell Smith, Eli Lilly & Company
Statistical Methods in Assay Validation
Monday, September 24, 2001, 4:30 PM in LAEB B222
Dr. Brian Smith, Eli Lilly & Company
Clinical Pharmacology Statistics
Monday, October 1, 2001, 4:30 PM in LAEB B222
Dr. Doug Faries, Eli Lilly & Company
Statistical Issues in Phase II Trials: Reaching a Product Decision
Monday, October 8, 2001
No Seminar
October Break
Monday, October 15, 2001, 4:30 PM in LAEB B222
Dr. Jay Andersen, Eli Lilly & Company
Applications of Decision Analysis in the Pharmaceutical Industry
Monday, October 22, 2001, 4:30 PM in LAEB B222
Dr. Kristi Griffiths, Eli Lilly & Company
A Statistician's Role in Drug Product Development
Monday, October 29, 2001, 4:30 PM in LAEB B222
Wherly P Hoffman, Ph.D. and Daniel Ness, DVM, Ph.D., Eli Lilly & Company
Statistics in Toxicology
Monday, November 5, 2001, 4:30 PM in LAEB B222
Dr. Roy Tamura, Eli Lilly & Company
Comparing the Time to Response in Antidepressant Clinical Trials
Presentation Slides (PowerPoint)
Monday, November 12, 2001, 4:30 PM in LAEB B222
Dr. Bill Huster, Eli Lilly & Company
From Product Decision to Regulatory Submission (and beyond!)
Monday, November 19, 2001, 4:30 PM in LAEB B222
Dr. Bob Obenchain, Eli Lilly & Company
Adjustment for Treatment Selection Bias in Retrospective Studies
Monday, November 26, 2001, 4:30 PM in LAEB B222
Rebecca Elliott, Eli Lilly & Company
Dose Control in Parenteral Manufacturing
Monday, December 3, 2001, 4:30 PM in LAEB B222
Dan Lockhart, Ph.D., Eli Lilly & Company
Applications of Statistics in Pharmaceutical Marketing Research